MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/ijms222212416

Медицинская библиотека · International journal of molecular sciences · 2021

MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.

Rapanotti Maria Cristina, Cugini Elisa, Nuccetelli Marzia, Terrinoni Alessandro, Di Raimondo Cosimo, Lombardo Paolo, Costanza Gaetana, Cosio Terenzio, Rossi Piero, Orlandi Augusto, Campione Elena, Bernardini Sergio, Blot-Chabaud Marcel, Bianchi Luca

СтатьяПеревод пока не подготовлен

Аннотация

Human malignant melanoma shows a high rate of mortality after metastasization, and its incidence is continuously rising worldwide. Several studies have suggested that MCAM/MUC18/CD146 plays an important role in the progression of this malignant disease. MCAM/MUC18/CD146 is a typical single-spanning transmembrane glycoprotein, existing as two membrane isoforms, long and short, and an additional soluble form, sCD146. We previously documented that molecular MCAM/MUC18/CD146 expression is strongly associated with disease progression. Recently, we showed that MCAM/MUC18/CD146 and ABCB5 can serve as melanoma-specific-targets in the selection of highly primitive circulating melanoma cells, and constitute putative proteins associated with disease spreading progression. Here, we analyzed CD146 molecular expression at onset or at disease recurrence in an enlarged melanoma case series. For some patients, we also performed the time courses of molecular monitoring. Moreover, we explored the role of soluble CD146 in different cohorts of melanoma patients at onset or disease progression, rather than in clinical remission, undergoing immune therapy or free from any clinical treatment. We showed that MCAM/MUC18/CD146 can be considered as: (1) a membrane antigen suitable for identification and enrichment in melanoma liquid biopsy; (2) a highly effective molecular "warning" marker for minimal residual disease monitoring; and (3) a soluble protein index of inflammation and putative response to therapeutic treatments.

Для цитирования: Rapanotti Maria Cristina, Cugini Elisa, Nuccetelli Marzia, Terrinoni Alessandro, Di Raimondo Cosimo, Lombardo Paolo, Costanza Gaetana, Cosio Terenzio, Rossi Piero, Orlandi Augusto, Campione Elena, Bernardini Sergio, Blot-Chabaud Marcel, Bianchi Luca. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.. International journal of molecular sciences. 2021. DOI: 10.3390/ijms222212416.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.